Effects of different dosages of vitamin D3 on anthropometric indices, metabolic, bone, and vascular parameters and body compositio

Phase 3

Completed

• Conditions: Condition 1: over weight and obesity, cardiovascular disease. Condition 2: vitamin D deficiency.; Overweight and obesity; Vitamin D deficiency

• Registration Number: IRCT20180805040703N1
• Lead Sponsor: Institute for Endocrine Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 14 January 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 327

Inclusion Criteria

Willingness to cooperate
Age 6-13 years
Overweight or obesity (BMI = 85th percentile national scale by age and sex)

Exclusion Criteria

Reluctance to cooperate in any stage of study
Use of any vitamin D supplements during the last six months
Identifying any types of liver diseases, kidney, cardiovascular and metabolic bone
Use of any drugs, affecting metabolism of vitamin D including glucocorticoids, steroids and anticonvulsants such as carbamazepine, phenytoin and phenobarbital
Following any weight loss diets during the past one year

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Carotid intima media thickness. Timepoint: before intervention, 6 and 12 months after intervention. Method of measurement: sonography.